Company intelligence / Profile preview

Active Implants LLC

Memphis, Tennessee, United Statesnusurfaceimplant.com ↗

Ownership: Private
Employees: ~38
Development stage: Commercial

Overview

The company's flagship product, NUsurface® Meniscus Implant, received FDA Breakthrough Device Designation. It completed enrollment in clinical trials in 2018 and was planning FDA submission data in 2019-2020. The product is designed for patients with persistent knee pain following meniscus surgery who are too young for total knee replacement[4].

Therapeutic areas: Rheumatology
Modalities: Orthopedic implantscushion-bearing implants
Industry: Implantable Medical Devices

Drug pipeline

1 asset

NUsurface Meniscus Implant

Commercial

Indications: Meniscal injury, Knee pain

Beyond the preview

Go deeper on Active Implants LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Active Implants LLC.

Explore the full profile